期刊名称：AIDS RESEARCH AND HUMAN RETROVIRUSES
 期刊简介(About the journal)
投稿须知(Instructions to Authors)
编辑部信息(Editorial Board)
About the journal
AIDS RESEARCH AND HUMAN RETROVIRUSES Contains peer-reviewed original papers in the multidisciplinary study of retrovirus-associated diseases with emphasis on HIV. This journal covers the investigations of new viruses pertaining to cancer, degenerative diseases, and the immune system in general. Indexed in Index Medicus, Medline, EMBASE, Excerpta Medica, Current Contents/Life Sciences, ISI/Biomed, Science Citation Index-Expanded, International Bibliography of Periodical Literature, International Bibliography of Book Reviews and SIIC databases.
Instructions to Authors
AIDS RESEARCH AND HUMAN RETROVIRUSES is a peer-reviewed journal in the English language. The Journal will publish Full and Short Communications, Letters to the Editor, Perspectives, Sequence Notes, Mini-reviews, and Conference or Workshop Summaries as deemed appropriate.
Full Communications should be presented in the format described below.
Short Communications, also subject to peer-review, are intended for the presentation of brief observations that do not warrant a full-length text, but also are not preliminary results. Include an abstract; do not use section headings in the body of the text; report methods, results, and discussion in a single section. Reference citations are identical in style to those of full-length papers, but appropriately abbreviated.
Letters to the Editor can be on any issue relevant to the field of human retroviruses. They must be brief (one or two journal pages) and appropriately documented by data. Letters can be sent to the Editor-in-Chief or to the basic science or clinical Editors, and may be subject to review.
Mini-reviews and Perspectives may be solicited by the Editors or submitted independently. Mini-reviews are brief summaries of new developments in the field of human retroviruses. Perspectives are more representative of an opinion about an area of the field or a direction of research. The length for either should not exceed seven journal pages, and both may be subject to peer-review.
Sequence Notes offer more rapid publication of papers that present novel sequence data in a brief format. They are generally no more than 3 or 4 journal pages. Include an abstract of not more than 150 words, but do not use section headings in the text, and limit the references to 15. Sequence Notes are submitted in duplicate directly to the Sequence Note Editor. Allow 2-3 weeks for the initial evaluation.
Basic Sciences
Molecular Biology桞eatrice Hahn, M.D., University of Alabama, Department of Medicine, 720 South 19th Street, KAUL 816, Birmingham, AL 35294-002
Biology-Birgitta 舠j? M.D., Ph.D. c/o University of Alabama, US Mail: BBRB 256, 1530 3rd Ave. S, Street address: 845 19th Street South, BBRB 256, Birmingham, AL 35294-2170, (205) 975-7045, ARHR@uab.edu;
Immunology桬dgar G. Engleman, M.D., Stanford Blood Center, Stanford University, 800 Welch Road, Palo Alto, CA 94304, (650) 723-7960;
Pathogenesis桼ichard Koup, M.D., Chief, Immunology Laboratory, NIH Vaccine Research Center, Building 40, Room 3502, 40 Covent Drive, Bethesda, MD 20892, (301) 594-8574;
Vaccines桸orman Letvin, M.D., Beth Israel Deaconess Medical Center, Research East/113, 330 Brookline Avenue, Boston, MA 02215, (617) 667-2766
Epidemiology桽usan Buchbinder, M.D., San Francisco Dept. of Public Health, 25 Van Ness Avenue, Suite 500, San Francisco, CA 94102-6033, (415) 554-9030;
Animal Models桼onald C. Desrosiers, Ph.D., New England Regional Primate Research Center, Divisions of Microbiology and Molecular Genetics, One Pine Hill Drive, Southborough, MA 01772, (508) 624-8099;
Other Human Retroviruses桵itsuaki Yoshida, Ph.D., Banyu Tsu-kuba Research Institute, Ohkubo 3, Tsukuba, Ibaraki 300-2611, Japan, 81-298-77-2000, 81-298-77-2034 (fax). E-mail: yoshimx@banyu.co.jp;
Sequence Notes桞rian Foley, Ph.D., HIV Sequence Database, Los Alamos National Laboratory, Group T-10, Mail Stop K710, Los Alamos, NM 87545, (505) 665-1970. E-mail: btf@lanl.gov.
Clinical Investigations
Pharmacology and Clinical Trials桟harles Flexner, M.D., Johns Hopkins University Hospital, Clinical Pharmacology, Olser 524, 600 North Wolfe Street, Baltimore, MD 21287, (410) 955-9712 (Fax) 410-614-9978, E-mail flex@erols.com
Opportunistic Infections梂illiam G. Powderly, M.D., Washington University School of Medicine, 660 South Euclid Ave., Box 8051, St. Louis, MO 63110, (314) 454-8214;
Editor-in-Chief: Eric Hunter, Ph.D., The University of Alabama at Birmingham, US Mail: BBRB 256, 1530 3rd Ave S, Street address: 845 19th Street South, BBRB 256, Birmingham, AL 35294-2170, (205) 934-4321, ARHR@uab.edu; or to the
Senior Clinical Editor: Michael S. Saag, M.D., UAB AIDS Outpatient Clinic, University of Alabama at Birmingham, 908 20th Street, South, Birmingham, AL 35294, CCB 142, (205) 934-7349.
All submissions will be acknowledged. Authors should call the appropriate editor if receipt has not been confirmed within 30 days of mailing or courier delivery.
PREPARATION OF MANUSCRIPT
Follow all submission guidelines to avoid delays in processing and publication. Type manuscripts double-spaced (6mm minimum) on 8" ?x 11" paper. Leave ample margins on the sides, top, and bottom of the page (minimum 1" left/right, 1 ? top/bottom). Manuscripts should be submitted in triplicate (the original and two copies), plus three sets of high quality figures. Manuscripts should be submitted double-spaced on 8 ?x 11 paper. Leave ample margins on both sides, top and bottom. Submit the original and three copies, including original illustrations, figures, and tables. Disk submission is required, and the disk must match the hard copy exactly. Disks may be submitted in either PC or Macintosh formats, preferably in Microsoft Word or Word Perfect.
The title page should include the authors?names and affiliations, and a running title of about 45 characters, including spaces. Please indicate contact information for the corresponding author, including a mailing and/or street address, telephone and fax numbers, and e-mail address. The second page must consist of an abstract of not more than 250 words, which should be self-explanatory without reference to the text. Full communications are structured using the following headings: abstract, introduction, materials and methods, results, discussion, acknowledgments, sequence data, and references. Number pages consecutively. At the end of the manuscript, give the name and address of the individual to whom reprint requests should be directed. The inclusion of that person抯 e-mail address is also strongly encouraged.
The authors may suggest suitable referees in a cover letter, but must provide accurate contact information for all such individuals, including fax numbers. Please follow the requested style to avoid delays in publication.
NOMENCLATURE. AIDS RESEARCH AND HUMAN RETROVIRUSES has adopted the recommendations of the Executive Committee of the International Committee on Taxonomy of Viruses (ICTV) (Ref: Science 232:1486, 1986, and Nature 321:644, 1986) to designate viruses associated with AIDS. The Committee抯 suggestion was to use HIV (human immunodeficiency virus) or the generic name for this class of human retroviruses. The Committee also recommended maintaining the specific strain names (LAV-1BRU, LAV-1LOI, HTLV-IIIB, HTLV-IIIRF, ARV1 . . .) in the interest of continuity and appreciation for the biologic and molecular differences of the individual strains. Thus, for the sake of accuracy, the editors encourage the use of specific strain names in experimental details.
SEQUENCE DATA. AIDS RESEARCH AND HUMAN RETROVIRUSES requires submission of accession numbers with any manuscript that uses sequence data. The numbers must be listed in a separate section following acknowledgments. Accession numbers can be obtained from Genbank, EMBL, or DDBJ. See http://www.ncbi.nlm.nih.gov/Web/Genbank/submit.html for information, or send e-mail to info@ncbi.nlm.nih.gov
TABLES. Type each table with its title on a separate sheet of paper. Use Arabic numerals to number tables. Each table must stand alone, i.e., contain all necessary information in the caption, and the table itself must be understood independently of the text. Details of experimental conditions should be included in the table footnotes. Table legends and footnotes should be double-spaced. Information that appears in the text should not be repeated in tables, and tables should not contain data that can be given in the text in one or two sentences.
ILLUSTRATIONS. Original line art, graphs, and glossy photographs for all halftone illustrations should be supplied with the original manuscript. Photocopies cannot be used for reproduction. All figures should be identified on the back by number and the first author抯 name. The top of the illustration should be indicated. A list of figure legends should be supplied at the end of the manuscript, double-spaced. Magnifications should be included when appropriate. Keep graphs simple. Illustrations will not be returned unless requested.
Illustrations may be submitted on disc. Clearly label the disc with the program used and accompany it with hard copy. Be sure the disc contains only the required illustrations, each clearly identified. For e-mailing attachment files, first contact publisher for instructions.
Color Artwork桾he Journal will publish color illustrations, but the author must subsidize the cost of the color printing. For further details, contact the Publisher.
ACKNOWLEDGMENTS. Collaborations, sources of research funds, and other acknowledgments should be listed in a separate section at the end of the text ahead of the REFERENCES section.
REFERENCES. All references must be cited in the text. Cite references within the text by a superscript Arabic number. Number references in the order that they appear in the text. Double-space the references and triple-space between each listing. When there are more than six authors, it is acceptable to list the first three followed by "et al." Use the appropriate styles:
Journals: (1) surname of author(s), initials, (2) paper title, (3) journal, (4) year of publication, (5) volume number, and (6) first and last page of citation. Example: Williams N: T cells on the mucosal frontline. Science 1998;280:198?00.
Books: (1) surname of author(s), initials, (2) chapter title, (3) title of book, (4) editors of book (if applicable), (5) edition of book (if applicable), (6) publisher, (7) city of publication, (8) year of publication, and (9) first and last page reference. Example: Bolognesi D: HIV vaccines. In: Immunology of HIV infection. (Gupta S, ed.) Plenum Medical, New York, 1996, pp. 561?76.
Patents: (1) country of original registration, (2) patent number, (3) month, day, and year of issuance.
When data from an unpublished source are presented, supply complete information, e.g., researcher抯 name and location. If work is in press, give the journal in which it is to be published or the publisher.
PERMISSIONS. The author must obtain permission to reproduce figures, tables, and text from previously published material. Written permission must be obtained from the original copyright holder (generally the publisher, not the author or editor) of the journal or book concerned. An appropriate credit line should be included in the figure legend or table footnote, and full publication information should be included in the reference list. Written permission must be obtained from the author of any unpublished material cited from other laboratories, and should accompany the manuscript. All permissions listings must be shown in manuscript梩hey cannot be entered on proofs.
FEES and REPRINTS. To help defray the cost of printing, the publisher requests that charges of $60 per printed page be paid by all authors who have funds available from research grants or from their institutions. However, the ability to pay page charges is not a prerequisite for publication. Reprints may be ordered by using the special reprint order form that accompanies the proofs. Reprints ordered after the issue is printed will be charged at a substantially higher rate.
PUBLISHER
The Journal is published monthly by Mary Ann Liebert, Inc., publishers, 2 Madison Avenue, Larchmont, NY 10538-1962. Telephone: (914) 834-3100; fax: (914) 834-3771; e-mail: info@liebertpub.com; internet: www.liebertpub.com
Editorial Board
The Official Journal of the International Retrovirology Association
Editor-in-Chief
Eric Hunter, Ph.D.
Professor of Microbiology
Director, Center for AIDS Research
The University of Alabama at Birmingham
US Mail:
BBRB 256, 1530 3rd Ave S
Street address:
845 19th Street South, BBRB 256
Birmingham, AL 35294-2170
(205) 934-4321
ARHR@uab.edu
Editorial Office:
205-975-7045
Senior Clinical Editor
Michael S. Saag, M.D.
Professor of Medicine
Director, UAB AIDS Outpatient Clinic
University of Alabama at Birmingham
908 20th Street, South CCB 142
Birmingham, AL 35294
(205) 934-7349
Editors-Basic Sciences
Molecular Biology
Beatrice Hahn
University of Alabama
Department of Medicine
720 South 19th Street, KAUL 816
Birmingham, AL 35294-0024
Cell Biology
Birgitta Asjo
Centre for Research in Virology
University of Bergen
Bergen, Norway
Immunology
Edgar G. Engleman
Stanford Blood Center
Stanford University
800 Welch Road
Palo Alto, CA 94304
Pathogenesis
Richard Koup
Vaccine Research Center
NIAID/NIH
Building 40, Room 3502
40 Covent Drive, MSC 3022
Bethesda, MD 20892
Vaccines
Norman L. Letvin
Beth Israel Deaconess
Medical Center
Research East/113
330 Brookline Avenue
Boston, MA 02215
Epidemiology
Susan Buchbinder
San Francisco Dept. of Public Health
25 Van Ness Avenue, Suite 500
San Francisco, CA 94102-6033
Animal Models
Ronald C. Desrosiers
Harvard Medical School
Box 9102
New England Regional Primate Research Center
One Pine Hill Drive
Southborough, MA 01772-9102
Other Human Retroviruses
Mitsuaki Yoshida
Banyu Tsukuba Research Institute
Ohkubo 3, Tsukuba
Ibaraki 300-2611, Japan
Sequence Notes
Brian Foley
HIV Sequence Database
Los Alamos National Laboratory
Group T-10, Mail Stop K710
|
刊名字顺( Alphabetical List of Journals):
返回页首 